Leprosy Post-Exposure Prophylaxis Project

The overall aim of the collaboration on the leprosy post-exposure prophylaxis (LPEP) project is for chemoprophylaxis to become routine for contact persons of newly diagnosed patients, as the project will demonstrate that it is an effective and feasible way to interrupt the further transmission of leprosy.

Leprosy Post-Exposure Prophylaxis Project

The Novartis Foundation for Sustainable Development and Netherlands Leprosy Relief (NLR) is collaboration with national leprosy programs and other International Federation of Anti-Leprosy Associations (ILEP) partners to interrupt transmission of leprosy. In pilot sites of several countries across Asia, Africa and Latin America, the collaboration aims at introducing leprosy post-exposure prophylaxis (PEP) for contact persons of newly diagnosed patients to decrease their risk of developing leprosy.

Called Leprosy Post-Exposure-Prophylaxis (LPEP) project, the collaboration aims at providing critical evidence on the impact of PEP on case detection rates and at demonstrating the feasibility, acceptability and cost implications of chemoprophylaxis for contact persons of newly diagnosed patients, as a strategy to interrupt leprosy transmission.

Preventative treatment of contacts of newly diagnosed leprosy patients is part of a new leprosy strategy announced late last year by the Novartis Foundation. The strategy aims at finally ending the disease worldwide by shifting the focus to the interruption of disease transmission. The way toward reducing leprosy transmission, as defined by a group of leading experts, is through early diagnosis and prompt treatment of all patients, tracing and PEP for contact persons of newly diagnosed leprosy patients, the development of new diagnostic tools, as well as strict epidemiological surveillance and response systems to monitor progress.

The LPEP project will be launched with an inception workshop from June 10 to 12, 2014 in Surabaya, Indonesia. National program managers from several leprosy endemic countries are joining this workshop to establish the LPEP roadmap and implementation plans for individual countries.


  • Novartis Foundation

    Switzerland | Staff size: 26-50

    The Novartis Foundation is a philanthropic organization pioneering innovative healthcare models that have a transformational impact on the health of the poorest populations. We work hand-in-hand...

  • Leprastichting (Netherlands Leprosy Relief)

    Implementing NGO
    United States | Staff size: 101-250

    NLR is committed to creating a world free of the suffering caused by leprosy. Founded in 1967, this Dutch organisation is now an international forerunner in leprosy control. NLR combats leprosy...

  • The International Federation of Anti-Leprosy Associations (ILEP)

    Implementing NGO, Association
    Switzerland | Staff size: 1-5

    ILEP (The International Federation of Anti-Leprosy Associations) is a federation of autonomous anti-leprosy non-governmental organisations, which are supporting medical, scientific, social and...

More Resources

Key Information

LocationCambodia, East Asia and Pacific
  • Start Date 2014